Literature DB >> 14398886

The neuromuscular blocking properties of a series of bis-quaternary tropeines.

C G HAINING, R G JOHNSTON, J M SMITH.   

Abstract

Linkage of two tropine esters through their nitrogen atoms by the chain -[CH(2)](m)-O-CO-[CH(2)](n)-CO-O-[CH(2)](m)-, in which m was 2 or 3 and n varied from 0 to 6, gave compounds which produced neuromuscular block without depolarization. Reversibility be neostigmine was confirmed for a few compounds. Potency was found to depend upon the tropine ester employed and upon the values of n and m. Short duration and hypotensive properties were favoured by the higher values of n. The duration of action of the compound based on the phenylacetic acid ester of tropine, in which n=4 and m=2, varied considerably in different species. Epimerization, in which the relative positions of the methyl group and the linking chain on the quaternary tropane nitrogen atom were reversed, did not produce subtances having more favourable properties than those possessed by the unepimerized compounds.

Entities:  

Keywords:  MYONEURAL JUNCTION/pharmacology

Mesh:

Substances:

Year:  1960        PMID: 14398886      PMCID: PMC1481991          DOI: 10.1111/j.1476-5381.1960.tb01212.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  11 in total

1.  Pharmacology of diammonio esters.

Authors:  J HIDALGO; W WILKEN; V P SEEBERG; I GRIGSBY; J GULDENZOPF
Journal:  Arch Int Pharmacodyn Ther       Date:  1959-01-01

2.  Neuromuscular blocking agnets of short duration.

Authors:  C G HAINING; R G JOHNSTON; J M SMITH
Journal:  Nature       Date:  1959-02-21       Impact factor: 49.962

3.  The use of a homatropinium derivative to produce controlled hypotension.

Authors:  J D ROBERTSON; J GILLIES; K E SPENCER
Journal:  Br J Anaesth       Date:  1957-08       Impact factor: 9.166

4.  Dicholinesters of alpha, omega-dicarboxylic acids and related substances.

Authors:  F BRUCKE
Journal:  Pharmacol Rev       Date:  1956-06       Impact factor: 25.468

5.  The use and limitations of atropine for pharmacological studies on autonomic effectors.

Authors:  N AMBACHE
Journal:  Pharmacol Rev       Date:  1955-12       Impact factor: 25.468

6.  [Belladonnin-bromethylate, a new muscle relaxant].

Authors:  O JUST
Journal:  Anaesthesist       Date:  1953-10       Impact factor: 1.041

7.  Studies on cholinergic blocking substances. II. Correlations between structure and effect in antimuscarine, ganglion blocking and curare-like actions of mono- and bis-quaternary ammonium compounds.

Authors:  L GYERMEK; K NADOR
Journal:  Acta Physiol Acad Sci Hung       Date:  1952

8.  Assay of histamine on the isolated guinea-pig intestine by the method of superfusion.

Authors:  H M ADAM; D C HARDWICK; K E SPENCER
Journal:  Br J Pharmacol Chemother       Date:  1954-09

9.  Curare-like action of decamethylene-bis(atropinium iodide).

Authors:  K K KIMURA; K R UNNA
Journal:  J Pharmacol Exp Ther       Date:  1950-03       Impact factor: 4.030

10.  The action of d-tubocurarine chloride on foetal neuromuscular transmission and the placental transfer of this drug in the rabbit.

Authors:  A J BULLER; I M YOUNG
Journal:  J Physiol       Date:  1949-09       Impact factor: 5.182

View more
  4 in total

1.  The pharmacology of pancuronium bromide (Org.NA97), a new potent steroidal neuromuscular blocking agent.

Authors:  W R Buckett; C E Marjoribanks; F A Marwick; M B Morton
Journal:  Br J Pharmacol Chemother       Date:  1968-03

2.  Pharmacological and certain chemical properties of AH 10407, an unusually short-acting, competitive neuromuscular blocking drug, and some related compounds.

Authors:  R T Brittain; D Jack; M B Tyers
Journal:  Br J Pharmacol       Date:  1977-09       Impact factor: 8.739

3.  Neuromuscular blocking properties of some bistropinium esters.

Authors:  C G HAINING; R G JOHNSTON
Journal:  Br J Pharmacol Chemother       Date:  1962-04

4.  The margin of safety of neuromuscular transmission.

Authors:  W D Paton; D R Waud
Journal:  J Physiol       Date:  1967-07       Impact factor: 5.182

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.